Pear Therapeutics, Inc.·4

Dec 7, 5:26 PM ET

Gomez Jorge M 4

4 · Pear Therapeutics, Inc. · Filed Dec 7, 2021

Insider Transaction Report

Form 4
Period: 2021-12-03
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-03+70,67570,675 total
    Exercise: $9.28Exp: 2031-10-29Common Stock (70,675 underlying)
Footnotes (2)
  • [F1]33% of the shares underlying the option shall vest on August 19, 2022, 33% of the shares underlying the option shall vest on August 19, 2023 and 34% of the shares underlying the option shall vest on August 19, 2024.
  • [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 48,000 shares of common stock of Private Pear for $13.65 per share.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES